Join Qinecsa at DIA Global Annual Meeting 2024
May 14, 2024
Qinecsa is thrilled to announce exhibiting at the DIA Global Annual Meeting, happening from June 16th to 20th in San Diego, CA. Redefining Healthcare through
Qinecsa is thrilled to announce exhibiting at the DIA Global Annual Meeting, happening from June 16th to 20th in San Diego, CA. Redefining Healthcare through
On April 17, 2024, Qinecsa launched its first webinar, offering a deep dive into medical device regulations. The on-demand session, “Mastering Medical Device Regulations (EU)
Webinar: Vigilance Medical Device Guidance – Part 1 Mastering Medical Device Regulations (EU) 2017/745 In this webinar, you will find an in-depth presentation of medical
Drug safety is critical to protect patients and consumers exposed to pharmaceutical development and commercialized drugs. Although the principal framework for Drug Safety and PV
Press Release Qinecsa Solutions announces acquisition of Insife to expand its end-to-end pharmacovigilance technology solutions. 21st March 2024 — Qinecsa Solutions (Qinecsa), specialists in technology-led
Drug safety leaders speak There are thousands of small pharma and biotech companies around the world. Yet when it comes to drug safety, these organizations
Qinecsa is excited to be exhibiting for the first time at the DIA Europe regional annual meeting from 12-14 March at the SQUARE Brussels Meeting
Qinecsa specializes in technology-led, end-to-end pharmacovigilance solutions, built on over 20 years of heritage expertise. As a trusted global partner, we combine best-in-class technology with
Reportum is a unified adverse event platform managing both digital and analogue intake from all sources. It offers a digital-first experience for consumers and healthcare
Qinecsa provide quality and compliance services to support clients in audit and inspection readiness, SOP writing, data privacy adherence, pharmacovigilance training, PSMF maintenance and CAPA
2 Leman Street,
London, E1W 9US
United Kingdom
Company number: 13916274
